Abstract
Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19). We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally defined LOF variants underlying autosomal-recessive or autosomal-dominant deficiencies in 23 patients (3.5%) 17 to 77 years of age. We show that human fibroblasts with mutations affecting this circuit are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.
Highlights
Www.sciencemag.org (Page numbers not final at time of first release) 3 αβ α β α α α α www.sciencemag.org (Page numbers not final at time of first release) 4 μ α λ β μ μ α α β α μ www.sciencemag.org (Page numbers not final at time of first release) 5 κ www.sciencemag.org (Page numbers not final at time of first release) 6 γ κ www.sciencemag.org (Page numbers not final at time of first release) 7.
First release: 24 September 2020 www.sciencemag.org (Page numbers not final at time of first release) 2
Www.sciencemag.org (Page numbers not final at time of first release) β αγ β β β www.sciencemag.org (Page numbers not final at time of first release) α First release: 24 September 2020 α α λ www.sciencemag.org (Page numbers not final at time of first release) αβ γ www.sciencemag.org (Page numbers not final at time of first release) β www.sciencemag.org (Page numbers not final at time of first release) α α www.sciencemag.org (Page numbers not final at time of first release)
Summary
Www.sciencemag.org (Page numbers not final at time of first release) 3 αβ α β α α α α www.sciencemag.org (Page numbers not final at time of first release) 4 μ α λ β μ μ α α β α μ www.sciencemag.org (Page numbers not final at time of first release) 5 κ www.sciencemag.org (Page numbers not final at time of first release) 6 γ κ www.sciencemag.org (Page numbers not final at time of first release) 7.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
